NO991693L - Forbindelser og metoder for diagnose av tuberkulose - Google Patents

Forbindelser og metoder for diagnose av tuberkulose

Info

Publication number
NO991693L
NO991693L NO991693A NO991693A NO991693L NO 991693 L NO991693 L NO 991693L NO 991693 A NO991693 A NO 991693A NO 991693 A NO991693 A NO 991693A NO 991693 L NO991693 L NO 991693L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
polypeptides
methods
diagnosis
Prior art date
Application number
NO991693A
Other languages
English (en)
Norwegian (no)
Other versions
NO991693D0 (no
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S Vedvick
Daniel R Twardzik
Michael J Lodes
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO991693D0 publication Critical patent/NO991693D0/no
Publication of NO991693L publication Critical patent/NO991693L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO991693A 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose NO991693L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (fr) 1996-10-11 1997-10-07 Composes et procedes pour diagnostiquer la tuberculose

Publications (2)

Publication Number Publication Date
NO991693D0 NO991693D0 (no) 1999-04-09
NO991693L true NO991693L (no) 1999-06-09

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991693A NO991693L (no) 1996-10-11 1999-04-09 Forbindelser og metoder for diagnose av tuberkulose

Country Status (11)

Country Link
EP (1) EP0934415A2 (fr)
JP (1) JP2001500383A (fr)
AU (1) AU4750597A (fr)
BR (1) BR9712298A (fr)
CA (1) CA2268036A1 (fr)
CZ (1) CZ126699A3 (fr)
IL (2) IL129389A0 (fr)
NO (1) NO991693L (fr)
PL (1) PL333304A1 (fr)
TR (1) TR199901569T2 (fr)
WO (1) WO1998016645A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
CA2296419A1 (fr) * 1997-07-16 1999-01-28 Institut Pasteur Polynucleotide codant fonctionellement pour la proteine lhp de mycobacterium tuberculosis, fragments derives biologiquement actifs, et procedes utilisant ce polynucleotide
EP1484405A1 (fr) * 1997-11-10 2004-12-08 Statens Serum Institut Fragments d'acide nucléique et fragments polypeptidiques derivés de M. tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
EP1214088B1 (fr) 1999-05-04 2009-04-22 The University of Medicine and Dentistry of New Jersey Proteines exprimees par mycobacterium tuberculosis et non par bcg et employees en tant que vaccins et reactifs de diagnostic
ATE354663T1 (de) * 1999-10-07 2007-03-15 Corixa Corp Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
SI1542732T1 (sl) 2000-06-20 2010-01-29 Corixa Corp Csc The United Sta Fuzijski proteini Mycobacterium tuberculosis
WO2002004018A2 (fr) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Vaccin de mi-vie et procédé pour renforcer l'immunité anti-mycobactérienne
JP2005504523A (ja) 2001-06-22 2005-02-17 ヘルス プロテクション エージェンシー 低酸素圧下で発現するマイコバクテリア抗原
US7393540B2 (en) 2001-07-04 2008-07-01 Health Protection Agency Mycobacterial antigens expressed during latency
CN100351374C (zh) * 2001-07-25 2007-11-28 东曹株式会社 用于检测结核分枝杆菌的寡核苷酸和方法
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
SG159555A1 (en) 2004-11-16 2010-03-30 Crucell Holland Bv Multivalent vaccines comprising recombinant viral vectors
ATE543832T1 (de) 2005-04-29 2012-02-15 Glaxosmithkline Biolog Sa Verfahren zur vorbeugung oder behandlung einer m.-tuberculosis-infektion
US7993657B2 (en) * 2005-07-26 2011-08-09 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2368568A1 (fr) * 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions et procédés pour antigènes immunodominants
KR20120129927A (ko) 2010-01-27 2012-11-28 글락소 그룹 리미티드 변형된 투베르쿨로시스 항원
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (fr) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Polypeptides et peptides recombinantes, acides nucléiques lesencodantes, et l'utilisation de celles-ci pour le diagnostique de la tuberculose
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
DE69637879D1 (de) * 1995-09-01 2009-04-30 Corixa Corp Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
WO1997009429A2 (fr) * 1995-09-01 1997-03-13 Corixa Corporation Composes et methodes de diagnostic de la tuberculose

Also Published As

Publication number Publication date
TR199901569T2 (xx) 2000-12-21
PL333304A1 (en) 1999-11-22
JP2001500383A (ja) 2001-01-16
WO1998016645A3 (fr) 1998-08-06
CA2268036A1 (fr) 1998-04-23
AU4750597A (en) 1998-05-11
IL129389A0 (en) 2000-02-17
EP0934415A2 (fr) 1999-08-11
CZ126699A3 (cs) 1999-09-15
NO991693D0 (no) 1999-04-09
IL121936A0 (en) 1998-03-10
WO1998016645A2 (fr) 1998-04-23
BR9712298A (pt) 2000-10-24

Similar Documents

Publication Publication Date Title
NO995690L (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
DK1307564T3 (da) Forbindelser og fremgangsmåde til behandling og diagnose af chlamydiainfektion
WO2001062893A3 (fr) Composes et methodes de diagnostic et d'immunotherapie de la tuberculose
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
WO1998042740A3 (fr) COMPOSES ET PROCEDES DE DIAGNOSTIC ET DE TRAITEMENT DE L'INFECTION PAR $i(EHRLICHIA)
EP2192128A3 (fr) Composés et méthodes pour le traitement et le diagnostique des infections de Chlamydia
AU7312801A (en) Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
SE8900721D0 (sv) Methods for detection of antibodies to
EP1712629A3 (fr) Composés et procédés pour le diagnostic de la tuberculose
TH84254A (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
TH84254B (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application